Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Biofrontera Q2 FY26 net loss narrows to $0.6 million; revenue rises 32.9% to $12 million

Biofrontera Q2 FY26 net loss narrows to $0.6 million; revenue rises 32.9% to $12 million

ReutersReuters2026/08/13 12:51
  • Biofrontera Q2 2026 net product revenue rose 32.9% to USD 12 million; gross margin widened 9.2 percentage points to 80%.
  • GAAP net loss narrowed to USD 604,000, or USD 0.05 per share, from USD 5.3 million a year earlier.
  • Non-GAAP adjusted EBITDA improved to a loss of USD 170,000 from a loss of USD 5.14 million in the prior-year quarter.
  • First-half net product revenue increased 25.4% to USD 22.09 million; GAAP net loss narrowed to USD 5.36 million.
  • Management flagged an ITC exclusion order on the RhodoLED XL lamp that pulled forward some orders; pursuing a modified XL lamp.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biofrontera Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608130851PRIMZONEFULLFEED9809511) on August 13, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!